Manipal Health Enterprises DRHP & RHP
MainboardListedUpdated · GMP, subscription and listing data refresh through the day.
Manipal Health Enterprises IPO Details
Market capitalisation is the post-issue share count in the offer document’s capital structure (1,31,53,77,202 shares) multiplied by the upper end of the price band, ₹590. It is arithmetic on those two filed figures, not a valuation.
Manipal Health Enterprises Financials ₹ in crore
| ₹ crore | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | ₹6,171.63 | ₹8,242.25 | ₹10,335.75 |
| Expenses | — | — | — |
| Net profit (PAT) | ₹533.2 | ₹1,081.67 | ₹916.52 |
| PAT margin | 8.6% | 13.1% | 8.9% |
| Total assets | ₹10,818.83 | ₹14,072.08 | ₹24,864.5 |
Manipal Health Enterprises Shareholding before & after the IPO
The founding owners and their group entities.
Post-issue pattern as filed with the NSE. Pre-issue register from the RHP capital structure, cross-checked against exchange data. Pre-issue percentages are taken from the disclosure, never estimated.
Manipal Health Enterprises IPO Lot Size & Minimum Investment by investor category
| Application | Shares | Amount at ₹590 |
|---|---|---|
| Retail (min)1 lot | 25 | ₹14,750 |
| Retail (max)13 lots | 325 | ₹1,91,750 |
| sHNI (min)14 lots | 350 | ₹2,06,500 |
| bHNI (min)68 lots | 1,700 | ₹10,03,000 |
One lot is 25 shares, so a single application at the ₹590 cut-off costs ₹14,750. Retail applications are capped at ₹2,00,000, which is 13 lots for this issue. Amounts are shown at the upper band because applications are made at the cut-off price.
Manipal Health Enterprises DRHP & RHP offer documents
The draft red herring prospectus is filed with SEBI before the issue; the red herring prospectus adds the price band and dates just before bidding opens. Both describe the business, the restated financials, the risk factors and how the proceeds will be used.
Manipal Health Enterprises IPO Strengths & Risks as disclosed in the DRHP
How to check Manipal Health Enterprises IPO allotment status
Allotment is decided and published by the issue’s registrar, not by the exchange and not by alphave. For Manipal Health Enterprises Limited, the registrar is KFin Technologies Limited — allotment is finalised in the days between the issue closing on 31 Jul 2026 and listing on 05 Aug 2026.
Allotment and refund dates follow SEBI’s T+3 listing timeline in trading days and are tentative until the registrar and the exchange confirm them. alphave does not hold allotment results — only the registrar can show whether an application was allotted.
The registrar publishes allotment on its own portal: KFintech. Your bank will also show the blocked amount released if shares were not allotted.
Manipal Health Enterprises DRHP & RHP FAQs
Where can I read the Manipal Health Enterprises DRHP or RHP?
The offer document for the Manipal Health Enterprises Limited IPO is linked on this page as filed with the exchange; SEBI and the lead managers also host it.
What is a DRHP?
The Draft Red Herring Prospectus is the document a company files with SEBI before an IPO. It describes the business, the financials, the risk factors, the promoters and how the money raised will be used. The Red Herring Prospectus (RHP) is the version filed just before the issue opens, with the price band and dates added.
What are the strengths disclosed in the Manipal Health Enterprises DRHP?
The company is India's largest multispecialty hospital group by bed capacity with a pan-India presence. The company has the widest footprint in terms of presence of hospitals among private hospital chains in India. The company operates a patient-centric ecosystem rooted in transparency, and clinical and service excellence. The page lists all 8 as disclosed.
What are the key risks disclosed in the Manipal Health Enterprises DRHP?
The company's revenue from operations is derived substantially from Karnataka, and any loss of business or disruption in operations in Karnataka could have a material adverse effect. The company primarily generates revenue by providing inpatient care at its hospitals, and any inability to maintain or improve its admissions and hospital occupancy rates could adversely affect its business. The company derives a significant portion of its revenue from the CONGO-R specialties, and any negative changes in the demand for these specialties could adversely impact its business. The page lists all 8 disclosed risk factors.
Manipal Health Enterprises IPO Registrar where allotment and refund queries go
The registrar processes the allotment and the refunds. Contact details are as printed in the offer document; the exchange and your broker cannot change an allotment.
How to Apply for the Manipal Health Enterprises IPO ASBA and UPI, as SEBI sets them
- Apply through your broker’s IPO window or your bank’s net banking (ASBA). The money stays in your own account and is only blocked until allotment.
- Choose the number of lots and bid at the cut-off price. Retail applications are capped at ₹2,00,000; above that the bid moves to the non-institutional category.
- If you applied through a broker, approve the UPI mandate in your payment app. The mandate must be approved by 5 pm on the day after your bid, and by 5 pm on the closing day for bids made on the last day (31 Jul 2026).
- One application per PAN. A second application under the same PAN is rejected, and both may be.
- After allotment the blocked amount is released for shares not allotted. Allotment and refund queries go to the registrar, KFin Technologies Limited, not to the exchange or the broker.
What is GMP in an IPO?
Grey Market Premium is the price at which an unlisted IPO application or share changes hands informally, before the stock is listed on the exchange. It is quoted as a rupee figure over the issue price: a premium of ₹3 on a ₹590 upper band means the grey market is dealing at ₹593.
The grey market is an over-the-counter market between private dealers. It is not operated or supervised by NSE, BSE or SEBI, no trade is settled through a clearing corporation, and no dealer is obliged to publish or honour a quote. Figures are collected by third-party reporters and different sources routinely disagree, which is why a premium can move sharply within a day or vanish entirely once bidding closes.
Grey Market Premium is an unofficial, unregulated over-the-counter datapoint reported by third parties. It is not a price, a forecast, or an indication of listing gains, and is not investment advice.